Bio Special BioInvest

Agilent Reports Third-Quarter Fiscal Year 2022 Financial Results

Highlights: Revenue of $1.72 billion represents 8% reported growth year-over-year; and up 13% on a core(1) basis. GAAP net income of $329 million ...

 August 17, 2022 | News

10x Genomics Reports Second Quarter 2022 Financial Results

Recent Highlights Revenue was $114.6 million for the second quarter, representing a 1% decrease over the corresponding period of 2021. Announ...

 August 09, 2022 | News

Catalytic Investment to Improve Community Health Care for Millions Across Africa

Private sector investments to the Global Fund's Africa Frontline First Catalytic Fund from the Johnson & Johnson Foundation and the Skoll Foundation ...

 August 09, 2022 | News

Telix and University of Queensland-led Consortium Awarded $5M Australian Research Council (ARC) Grant

The ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR) aims to establish a manufacturing platform for new medical technolog...

 August 08, 2022 | News

Q2 2022: Merck Delivers Robust Growth Despite Headwinds

  Results of the second quarter of 2022 Group net sales rise by 14.3% to € 5.6 billion All business sectors contribute to strong...

 August 04, 2022 | News

Samsung Biologics Reports Second Quarter 2022 Financial Results

Released consolidated financial position of the company based on its full acquisition of Samsung Bioepis completed on April 20, 2022 Achieved recor...

 July 28, 2022 | News

Merck Launches its Uptune Program in Asia for Collaborating with Startups

  Application period for the Merck Uptune program starts today Topics vary from AI-enabled health and cell and gene therapy tools to innovative te...

 July 22, 2022 | News

Merck Launches its Uptune Program in Asia for Collaborating with Startups

Application period for the Merck Uptune program starts today Topics vary from AI-enabled health and cell and gene therapy tools to innovative technologi...

 July 15, 2022 | News

Qiming Venture Partners Announces Closing of Funds Totaling US$3.2 Billion

As in prior funds, Fund VIII was oversubscribed and reached its hard cap for limited partner commitments. This increases the firm's capital raised to ...

 July 12, 2022 | News

Capnopharm announces asset purchase of Capnomed to continue work on peritoneal cancer

Capnopharm GmbH announced it has entered into an asset purchase agreement to acquire all operating assets from Capnomed GmbH.Founded in 2015, Capnomed ha...

 July 11, 2022 | News

BRIM Biotechnology enters OTC trading in Taiwan

Established in July 2013, BRIM is a clinical-stage company developing novel regenerative therapies to help combat and cure ophthalmology and degenerative j...

 June 24, 2022 | News

Mojia Biotech Completes Series B Financing to Advance Manufacturing of Bio-based Materials

Mojia Biotech, a Shanghai-based leading bio-manufacturing company dedicated to sustainable development and carbon neutrality, announced the completion...

 June 23, 2022 | News

Agilent Reports Second-Quarter Fiscal Year 2022 Financial Results

Revenue of $1.61 billion represents 5% reported growth; and up 7% on a core(1) basis.  GAAP net income of $274 million with earnings per...

 June 21, 2022 | News

Merck Places Bonds Amounting to €1.0 billion

Merck, a leading science and technology company,  issued bonds amounting to € 1.0 billion. The revenue from the bond issue will be used for gener...

 June 20, 2022 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close